The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmacokinetics Testing Service Market Research Report 2025

Global Pharmacokinetics Testing Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1800101

No of Pages : 114

Ask Your Query
Synopsis
Global Pharmacokinetics Testing Service market is projected to reach US$ 535.5 million in 2029, increasing from US$ 327 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmacokinetics Testing Service market research.
The pharmacokinetics testing service market is expected to witness significant growth in the coming years. This can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and advancements in drug development and clinical trials.North America is expected to dominate the pharmacokinetics testing service market due to the presence of a well-established healthcare infrastructure, increasing R&D activities, and a large number of pharmaceutical companies in the region.Europe is also a significant market for pharmacokinetics testing services, driven by the presence of major pharmaceutical companies, increasing investments in drug development, and favorable government initiatives.The Asia Pacific region is expected to witness rapid growth in the pharmacokinetics testing service market due to the increasing outsourcing of drug development activities to countries like India and China, rising healthcare expenditure, and a large patient pool.The pharmacokinetics testing service market is highly fragmented, with the presence of numerous small and large players. However, a few major players dominate the market, accounting for a significant market share. These players have a strong presence in multiple regions and offer a wide range of pharmacokinetics testing services.The increasing focus on personalized medicine and targeted therapies presents significant opportunities for pharmacokinetics testing service providers. Personalized medicine requires precise pharmacokinetic data to determine the optimal drug dosage for individual patients.Technological advancements, such as the development of advanced analytical techniques and high-throughput screening methods, are expected to create new opportunities in the pharmacokinetics testing service market. These advancements enable faster and more accurate analysis of drug metabolism and pharmacokinetic parameters.The pharmacokinetics testing service market is subject to strict regulatory requirements, which can pose challenges for service providers. Compliance with regulatory guidelines and obtaining necessary approvals can be time-consuming and costly. Pharmacokinetics testing services can be expensive, especially for small and medium-sized pharmaceutical companies. The high cost of testing services can act as a barrier to market entry for some players and limit the adoption of these services.Overall, the pharmacokinetics testing service market is expected to grow significantly in the coming years, driven by factors such as the increasing demand for personalized medicine and advancements in drug development. However, challenges such as stringent regulatory requirements and high testing costs need to be addressed for the market to reach its full potential.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmacokinetics Testing Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Proteomics International
Labcorp
Pharmaron
Svar
NorthEast BioLab
BioAgilytix
Washington Biotechnology, Inc.（WBI）
Eurofins BioPharma
Charles River
SCAS
Chimera
Phoenix WinNonlin
CD bioparticles
ACM Global Laboratories
WuXi AppTec
BioGenes
Pacific BioLabs
XenoTech
Medpace
SGS
CellCarta
Precision
Segment by Type
Microscale Thermophoresis
Mass Spectrometry
Segment by Application
Drug Development
Clinical Trials
Veterinary Medicine
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmacokinetics Testing Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microscale Thermophoresis
1.2.3 Mass Spectrometry
1.3 Market by Application
1.3.1 Global Pharmacokinetics Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Development
1.3.3 Clinical Trials
1.3.4 Veterinary Medicine
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Testing Service Market Perspective (2018-2029)
2.2 Pharmacokinetics Testing Service Growth Trends by Region
2.2.1 Global Pharmacokinetics Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmacokinetics Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Pharmacokinetics Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Pharmacokinetics Testing Service Market Dynamics
2.3.1 Pharmacokinetics Testing Service Industry Trends
2.3.2 Pharmacokinetics Testing Service Market Drivers
2.3.3 Pharmacokinetics Testing Service Market Challenges
2.3.4 Pharmacokinetics Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Testing Service Players by Revenue
3.1.1 Global Top Pharmacokinetics Testing Service Players by Revenue (2018-2023)
3.1.2 Global Pharmacokinetics Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Pharmacokinetics Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Testing Service Revenue
3.4 Global Pharmacokinetics Testing Service Market Concentration Ratio
3.4.1 Global Pharmacokinetics Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Testing Service Revenue in 2022
3.5 Pharmacokinetics Testing Service Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Testing Service Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Testing Service Breakdown Data by Type
4.1 Global Pharmacokinetics Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Type (2024-2029)
5 Pharmacokinetics Testing Service Breakdown Data by Application
5.1 Global Pharmacokinetics Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmacokinetics Testing Service Market Size (2018-2029)
6.2 North America Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmacokinetics Testing Service Market Size by Country (2018-2023)
6.4 North America Pharmacokinetics Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetics Testing Service Market Size (2018-2029)
7.2 Europe Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmacokinetics Testing Service Market Size by Country (2018-2023)
7.4 Europe Pharmacokinetics Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Pharmacokinetics Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Testing Service Market Size (2018-2029)
9.2 Latin America Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmacokinetics Testing Service Market Size by Country (2018-2023)
9.4 Latin America Pharmacokinetics Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Pharmacokinetics Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proteomics International
11.1.1 Proteomics International Company Detail
11.1.2 Proteomics International Business Overview
11.1.3 Proteomics International Pharmacokinetics Testing Service Introduction
11.1.4 Proteomics International Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.1.5 Proteomics International Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Pharmacokinetics Testing Service Introduction
11.2.4 Labcorp Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.2.5 Labcorp Recent Development
11.3 Pharmaron
11.3.1 Pharmaron Company Detail
11.3.2 Pharmaron Business Overview
11.3.3 Pharmaron Pharmacokinetics Testing Service Introduction
11.3.4 Pharmaron Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.3.5 Pharmaron Recent Development
11.4 Svar
11.4.1 Svar Company Detail
11.4.2 Svar Business Overview
11.4.3 Svar Pharmacokinetics Testing Service Introduction
11.4.4 Svar Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.4.5 Svar Recent Development
11.5 NorthEast BioLab
11.5.1 NorthEast BioLab Company Detail
11.5.2 NorthEast BioLab Business Overview
11.5.3 NorthEast BioLab Pharmacokinetics Testing Service Introduction
11.5.4 NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.5.5 NorthEast BioLab Recent Development
11.6 BioAgilytix
11.6.1 BioAgilytix Company Detail
11.6.2 BioAgilytix Business Overview
11.6.3 BioAgilytix Pharmacokinetics Testing Service Introduction
11.6.4 BioAgilytix Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.6.5 BioAgilytix Recent Development
11.7 Washington Biotechnology, Inc.（WBI）
11.7.1 Washington Biotechnology, Inc.（WBI） Company Detail
11.7.2 Washington Biotechnology, Inc.（WBI） Business Overview
11.7.3 Washington Biotechnology, Inc.（WBI） Pharmacokinetics Testing Service Introduction
11.7.4 Washington Biotechnology, Inc.（WBI） Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.7.5 Washington Biotechnology, Inc.（WBI） Recent Development
11.8 Eurofins BioPharma
11.8.1 Eurofins BioPharma Company Detail
11.8.2 Eurofins BioPharma Business Overview
11.8.3 Eurofins BioPharma Pharmacokinetics Testing Service Introduction
11.8.4 Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.8.5 Eurofins BioPharma Recent Development
11.9 Charles River
11.9.1 Charles River Company Detail
11.9.2 Charles River Business Overview
11.9.3 Charles River Pharmacokinetics Testing Service Introduction
11.9.4 Charles River Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.9.5 Charles River Recent Development
11.10 SCAS
11.10.1 SCAS Company Detail
11.10.2 SCAS Business Overview
11.10.3 SCAS Pharmacokinetics Testing Service Introduction
11.10.4 SCAS Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.10.5 SCAS Recent Development
11.11 Chimera
11.11.1 Chimera Company Detail
11.11.2 Chimera Business Overview
11.11.3 Chimera Pharmacokinetics Testing Service Introduction
11.11.4 Chimera Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.11.5 Chimera Recent Development
11.12 Phoenix WinNonlin
11.12.1 Phoenix WinNonlin Company Detail
11.12.2 Phoenix WinNonlin Business Overview
11.12.3 Phoenix WinNonlin Pharmacokinetics Testing Service Introduction
11.12.4 Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.12.5 Phoenix WinNonlin Recent Development
11.13 CD bioparticles
11.13.1 CD bioparticles Company Detail
11.13.2 CD bioparticles Business Overview
11.13.3 CD bioparticles Pharmacokinetics Testing Service Introduction
11.13.4 CD bioparticles Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.13.5 CD bioparticles Recent Development
11.14 ACM Global Laboratories
11.14.1 ACM Global Laboratories Company Detail
11.14.2 ACM Global Laboratories Business Overview
11.14.3 ACM Global Laboratories Pharmacokinetics Testing Service Introduction
11.14.4 ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.14.5 ACM Global Laboratories Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Detail
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Pharmacokinetics Testing Service Introduction
11.15.4 WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.15.5 WuXi AppTec Recent Development
11.16 BioGenes
11.16.1 BioGenes Company Detail
11.16.2 BioGenes Business Overview
11.16.3 BioGenes Pharmacokinetics Testing Service Introduction
11.16.4 BioGenes Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.16.5 BioGenes Recent Development
11.17 Pacific BioLabs
11.17.1 Pacific BioLabs Company Detail
11.17.2 Pacific BioLabs Business Overview
11.17.3 Pacific BioLabs Pharmacokinetics Testing Service Introduction
11.17.4 Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.17.5 Pacific BioLabs Recent Development
11.18 XenoTech
11.18.1 XenoTech Company Detail
11.18.2 XenoTech Business Overview
11.18.3 XenoTech Pharmacokinetics Testing Service Introduction
11.18.4 XenoTech Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.18.5 XenoTech Recent Development
11.19 Medpace
11.19.1 Medpace Company Detail
11.19.2 Medpace Business Overview
11.19.3 Medpace Pharmacokinetics Testing Service Introduction
11.19.4 Medpace Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.19.5 Medpace Recent Development
11.20 SGS
11.20.1 SGS Company Detail
11.20.2 SGS Business Overview
11.20.3 SGS Pharmacokinetics Testing Service Introduction
11.20.4 SGS Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.20.5 SGS Recent Development
11.21 CellCarta
11.21.1 CellCarta Company Detail
11.21.2 CellCarta Business Overview
11.21.3 CellCarta Pharmacokinetics Testing Service Introduction
11.21.4 CellCarta Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.21.5 CellCarta Recent Development
11.22 Precision
11.22.1 Precision Company Detail
11.22.2 Precision Business Overview
11.22.3 Precision Pharmacokinetics Testing Service Introduction
11.22.4 Precision Revenue in Pharmacokinetics Testing Service Business (2018-2023)
11.22.5 Precision Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock